Over the last decade, there has been accumulating evidence for a role
of reactive oxygen metabolites in the pathogenesis of a variety of ren
al diseases, including gentamicin, glycerol, and cyclosporine A models
of toxic acute renal failure, Gentamicin has been shown in both in vi
tro and in vivo studies to enhance the generation of reactive oxygen m
etabolites, Iron is important in models of tissue injury, presumably b
ecause it is capable of catalyzing free radical formation, Gentamicin
has been shown to cause release of iron from renal cortical mitochondr
ia, Scavengers of reactive oxygen metabolites as well as iron chelator
s provide protection in gentamicin-induced nephrotoxicity. In glycerol
-induced acute renal failure, an animal model of rhabdomyolysis, there
is enhanced generation of hydrogen peroxide, and scavengers of reacti
ve oxygen metabolites and iron chelators provide protection, Although
the dogma is that the myoglobin is the source of iron, the results of
recent studies suggest that cytochrome P-450 may be an important sourc
e of iron in this model, In addition, there are marked alterations in
antioxidant defenses, such as glutathione, as well as changes in heme
oxygenase, Cyclosporine A has been shown to enhance the generation of
hydrogen peroxide in vitro and lipid peroxidation in vitro and in vivo
, Antioxidants have been shown to be protective in cyclosporine A neph
rotoxicity, This collective body of evidence suggests an important rol
e for reactive oxygen metabolites in toxic acute renal failure and may
provide therapeutic opportunities of preventing or treating acute ren
al failure in humans. (C) 1997 by the National Kidney Foundation, Inc.